Global, regional, and national burden of lymphoma from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 1990–2021
The socioeconomic level is closely related to the disease burden of lymphoma. It is necessary to strengthen global medical collaboration and resource allocation, especially to enhance the diagnosis and treatment capabilities in areas with low SDI. In the future, it is necessary to explore the interaction between environmental and genetic factors on lymphoma and formulate precise regional prevention and control strategies in order to reduce the disease burden and promote health equity.
Authors
- Hongyan Tong (ORCID: https://orcid.org/0000-0001-5603-4160)
- Xiaolong Zheng (ORCID: https://orcid.org/0000-0003-0405-5458)
- Jian Sun (ORCID: https://orcid.org/0000-0003-0067-5967)
- Yuanfei Shi
- Tianle Cao
- Yanchun Zhao
- Heli Wen
- Wanzhuo Xie
- Jie Jin
- Yamei Huang
- Lin Liu
- Yi Xu
Institutions
- Wannan Medical College (CN)
- Xinjiang Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Wenzhou Medical University (CN)
- Peking Union Medical College Hospital (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Second Affiliated Hospital of Xinjiang Medical University (CN)
- First Affiliated Hospital Zhejiang University (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1186/s40001-025-03832-5
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00